Clinical trial Recruiting at 2 sites Interventional Ages 18 to 45 Women only

TENS for pain relief during active labor

Official title: Transcutaneous Electrical Stimulation for Pain Reduction During Labor: A Crossover Clinical Trial.

Run by Universidad Nacional Autonoma de Honduras · NCT07401147 · Data updated 2026-11-12

This trial will try using a TENS device versus a sham to see if it lowers pain for first-time moms during the active phase of labor.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment132 (estimated)
SponsorUniversidad Nacional Autonoma de Honduras
Academic / other
Locations2 sites (Tegucigalpa, Francisco Morazán Department and 1 other locations)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedAugust 31, 2026
Study endsSeptember 15, 2026
Registry record updatedFebruary 13, 2026
Trial IDNCT07401147 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Nulliparous women aged 18–45 with a term (37–42 weeks) singleton cephalic pregnancy in active labor (≥5 cm dilation), with uncomplicated pregnancies and the ability to give informed consent.

Probably not a fit

Women with multiple pregnancy, non-cephalic presentation, severe obstetric complications, pre-pregnancy BMI over 30, neurological contraindications to TENS, or abnormal fetal monitoring are not expected to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, two-period crossover trial in nulliparous women at term comparing active transcutaneous electrical nerve stimulation (TENS) with a sham device during the active first stage of labor. Participants are randomized to receive active then sham or sham then active TENS with a standardized 30-minute washout between periods, using a commercial TENSCARE Perfect Mama+ unit with identical-appearing sham devices. The primary outcome is pain intensity measured by the Visual Analog Scale (VAS); secondary outcomes include duration of the active phase, maternal and neonatal safety, and childbirth satisfaction. The trial is conducted in the Labor and Delivery Unit at Hospital Escuela in Tegucigalpa, Honduras from Feb to Aug 2026.

Why it matters

Potential benefit: If successful, TENS could offer a simple, drug-free way to reduce pain during the first stage of labor and potentially lower the need for pharmacologic analgesics.

How similar studies have gone: Previous randomized trials of TENS in labor have produced mixed results, with some showing modest pain reduction and others little effect, so existing evidence is suggestive but not definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed informed consent.
* Women aged 18-45 years.
* Nulliparous.
* Term singleton pregnancy (37-42 weeks).
* Cephalic presentation.
* Spontaneous onset of labor or induced/conducted labor under adequate control.
* Cervical dilation of at least 5 cm at enrollment.
* Normal amniotic fluid volume and reassuring fetal monitoring.
* Uncomplicated pregnancy.

Exclusion Criteria:

* Multiple pregnancy.
* Non-cephalic presentation.
* Severe obstetric complications (e.g., preeclampsia, placental abruption).
* Maternal chronic or acute diseases interfering with safety.
* History of neurological/psychiatric disorders contraindicating TENS.
* Abnormal fetal monitoring or amniotic fluid.
* Pre-pregnancy BMI \>30 kg/m².
* Fetal demise.
* Illiteracy.

Where it's running

  • Hospital Escuela
    Tegucigalpa, Francisco Morazán Department, Honduras
    Recruiting
  • Instituto Hondureño de Seguridad Social
    Tegucigalpa, Francisco Morazán Department, Honduras
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.